Theodore P. Abraham, M.D.

84% fewer Medicare Part D claims than the average cardiovascular disease physician in 2024

497 Medicare Part D claims for 69 beneficiaries, against an average of 3,078 among the 20,728 providers of this specialty who prescribed in Part D. Brand-name drugs were 50% of claims.

Most prescribed

1. Camzyos184 claims
2. Metoprolol Succinate56 claims
3. Eliquis44 claims
4. Spironolactone36 claims
5. Candesartan Cilexetil35 claims
6. Carvedilol18 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 74.5 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $115.26

1 payment: food and beverage; the largest payer was E.R. Squibb & Sons, L.L.C. The 16,686 providers of this specialty with any payment received $3,819.56 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through 3 group practices

1. Regents OF The University OF CaliforniaSan Francisco, CA
2. Ucsf Medical Group Business ServicesSan Francisco, CA
3. University OF California San FranciscoSan Francisco, CA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).